scholarly journals Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI

2006 ◽  
Vol 119 (6) ◽  
pp. 467-473 ◽  
Author(s):  
Zheng-rong ZHOU ◽  
Tian-zhen SHEN ◽  
Xing-rong CHEN ◽  
Wei-jun PENG
2005 ◽  
Vol 62 (7-8) ◽  
pp. 525-528 ◽  
Author(s):  
Tatjana Stosic-Opincal ◽  
Mihail Gavrilov ◽  
Srboljub Stosic ◽  
Slobodan Lavrnic ◽  
Vesna Peric ◽  
...  

Aim. To evaluate the sensitivity of fluid-attenuated inversion recovery (FLAIR) sequence in the diagnosis and follow-up of the patients with low-grade astrocytomas compared with T2-weighted (T2W) sequence. Methods. Twenty-four patients with biopsy- confirmed low-grade astrocytoma (age range, 15-66 years) underwent T1- weighted (T1W), T2W and FLAIR imaging with a superconducting unit 1.0 T. FLAIR images were qualitatively evaluated by comparison with T2W images by the three experienced neuroradiologists. To evaluate the diagnostic value of FLAIR, the neuroradiologists individually assessed the possibilities of the detection of lesions, as well as the possibilities of the differentiation of tumor from the surrounding edema on FLAIR vs. T2W images. Every examiner ranked FLAIR sequence vs. T2W in three degrees: worse, equal and better. Results. The comparison of FLAIR with T2W spin-echo (SE) images with regard to the detection of the lesions showed that 82.8% of FLAIR studies were superior, 17.2% were of similar diagnostic value, and none was inferior to the T2W images. The comparison of images with regard to the differentiation of tumor boundaries vs. surrounding edema showed that 92.5% of FLAIR studies were superior, 7.5% were of similar diagnostic value, and none was inferior to the T2W images. Conclusion. Our results were similar to the previous studies' results concerning the advantages of FLAIR sequence in the diagnosis of low grade astrocytomas over T2W sequence. FLAIR was better at showing different tumor components, and at distinguishing CSF from the cystic component, and the postoperative cavity, compared with T2W images. Our conclusion was that FLAIR could be routinely used in the evaluation and follow-up of low-grade astrocytomas.


2008 ◽  
Vol 15 (1) ◽  
pp. 15-23 ◽  
Author(s):  
Mohammad Hadi Bagheri ◽  
Arash Meshksar ◽  
Seyyed Ali Nabavizadeh ◽  
Afshin Borhani-Haghighi ◽  
Nahid Ashjazadeh ◽  
...  

2008 ◽  
Vol 49 (4) ◽  
pp. 333-338 ◽  
Author(s):  
CRISTIAN FALZONE ◽  
FEDERICA ROSSI ◽  
MAURIZIO CALISTRI ◽  
MASSIMO TRANQUILLO ◽  
MASSIMO BARONI

2018 ◽  
Vol 5 (5) ◽  
pp. e480 ◽  
Author(s):  
Kianush Karimian-Jazi ◽  
Brigitte Wildemann ◽  
Ricarda Diem ◽  
Daniel Schwarz ◽  
Thomas Hielscher ◽  
...  

ObjectiveTo assess the diagnostic value of gadolinium (Gd) contrast administration in MRI follow-up examinations of patients with MS if the T2 lesion load is stable.MethodsWe included 100 patients with MS with at least 2 cranial MRI follow-up examinations (mean follow-up time 4.0 ± 2.6 years). MRI was performed at 3 Tesla with a standardized protocol including T2-weighted, fluid-attenuated inversion recovery (FLAIR) and T1-weighted contrast-enhanced sequences. Images were analyzed for T2/FLAIR and contrast-enhancing (CE) lesions by 3 independent neuroradiologists. Isolated Gd-enhancing lesions without correlate in T2 and FLAIR images, and reactivated Gd+ lesions were further assessed for size and signal intensity.ResultsWe identified a total of 343 new T2 lesions and 152 CE lesions in a total of 559 MRI follow-up examinations. New T2/FLAIR lesions were present in 30% of the scans. Of the Gd-enhancing lesions, 145/152 (95.4%) showed a correlate as a new T2/FLAIR lesion. There were 3 enhancing lesions (1.9% of all enhancing lesions) without T2/FLAIR correlate and 4 lesions (2.6%) that exhibited lesion reactivation or persistent enhancement over time. As a predictive factor of enhancement, we found that enhancing lesions had a higher T2 signal ratio (T2 SRlesion/normal-appearing white matter: 3.0 ± 0.1 vs 2.2 ± 0.1, p < 0.001).ConclusionThe likelihood of missing “active lesions” is overall small (1.7%) if T2 lesions are stable compared with the previous MRI examination. Lesion reactivation is rare. Our study indicates that Gd contrast administration might be dispensable in follow-up MRI of patients with MS if no new T2/FLAIR lesions and no new neurologic symptoms are present.


2000 ◽  
Vol 43 (3) ◽  
pp. 257
Author(s):  
Chan Kyo Kim ◽  
Dong Gyu Na ◽  
Wook Jae Ryoo ◽  
Hong Sik Byun ◽  
Hye Kyung Yoon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document